1. Home
  2. RNLX vs UTSI Comparison

RNLX vs UTSI Comparison

Compare RNLX & UTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNLX
  • UTSI
  • Stock Information
  • Founded
  • RNLX 2018
  • UTSI 1991
  • Country
  • RNLX United States
  • UTSI China
  • Employees
  • RNLX N/A
  • UTSI N/A
  • Industry
  • RNLX Medical Specialities
  • UTSI Telecommunications Equipment
  • Sector
  • RNLX Health Care
  • UTSI Telecommunications
  • Exchange
  • RNLX Nasdaq
  • UTSI Nasdaq
  • Market Cap
  • RNLX 26.1M
  • UTSI 25.7M
  • IPO Year
  • RNLX 2020
  • UTSI 2000
  • Fundamental
  • Price
  • RNLX $0.30
  • UTSI $2.46
  • Analyst Decision
  • RNLX Strong Buy
  • UTSI
  • Analyst Count
  • RNLX 1
  • UTSI 0
  • Target Price
  • RNLX $3.00
  • UTSI N/A
  • AVG Volume (30 Days)
  • RNLX 1.1M
  • UTSI 2.6K
  • Earning Date
  • RNLX 09-26-2024
  • UTSI 09-17-2024
  • Dividend Yield
  • RNLX N/A
  • UTSI N/A
  • EPS Growth
  • RNLX N/A
  • UTSI N/A
  • EPS
  • RNLX N/A
  • UTSI N/A
  • Revenue
  • RNLX $2,221,000.00
  • UTSI $14,958,000.00
  • Revenue This Year
  • RNLX $48.40
  • UTSI N/A
  • Revenue Next Year
  • RNLX $104.00
  • UTSI N/A
  • P/E Ratio
  • RNLX N/A
  • UTSI N/A
  • Revenue Growth
  • RNLX N/A
  • UTSI 14.41
  • 52 Week Low
  • RNLX $0.22
  • UTSI $2.20
  • 52 Week High
  • RNLX $2.76
  • UTSI $3.79
  • Technical
  • Relative Strength Index (RSI)
  • RNLX 43.79
  • UTSI 38.56
  • Support Level
  • RNLX $0.25
  • UTSI $2.74
  • Resistance Level
  • RNLX $0.32
  • UTSI $2.91
  • Average True Range (ATR)
  • RNLX 0.04
  • UTSI 0.16
  • MACD
  • RNLX -0.01
  • UTSI -0.04
  • Stochastic Oscillator
  • RNLX 29.88
  • UTSI 6.66

About RNLX Renalytix plc

Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

About UTSI UTStarcom Holdings Corp.

UTStarcom Holdings Corp operates as a telecom infrastructure provider. It develops technology for bandwidth from cloud-based services, mobile, streaming, and other applications. The range of solutions is designed to expand and modernize telecommunications networks through smooth network system integration, lower operating costs, and increased broadband access. The business activity of the firm is operated through the Equipment and Service segment. The Equipment segment is focused on equipment sales, including network infrastructure and application products, and the Service segment is engaged in providing services and support of equipment products and also the new operational support. The company operates in China, India, Japan, Taiwan and other countries.

Share on Social Networks: